Crystallization of phosphatidylinositol-specific phospholipase C from Bacillus cereus  by Bullock, T.L. et al.
Crystallization of phosphatidylinositol-specific phospholipase C from
Bacillus cereus
Timothy L. Bullock, Margret Ryan, Suezane L. Kim, S. James Remington, and 0. Hayes Griffith
Institute of Molecular Biology, University of Oregon, Eugene, Oregon 97403 USA
ABSTRACT Phosphatidylinositol-specific phospholipase C (PI-PLC) cleaves phosphoinositides into two parts, lipid-soluble diacylglycerol
and the water-soluble phosphorylated inositol. Two crystal forms of Bacillus cereus PI-PLC have been obtained by the vapor diffusion
technique. Hexagonal crystals were grown from solutions containing polyethylene glycol (PEG; 4,000 to 8,000 D). The space group of
these hexagonal crystals is P6122 (or the enantiomorphic space group P6522), with cell constants a = b = 133 A, and c = 231 A. The
crystals diffract to 2.8 A. The second crystalline form was grown from a two-phase PEG (600 D)-sodium citrate solution. The phase
diagram and PI-PLC distribution between phases has been determined. The enzyme crystallizes from the PEG-rich phase. The crystals
are orthorhombic with space group P212121 (a = 45 A, b = 46 A, c = 160 A), and contain one PI-PLC monomer per asymmetric unit. The
orthorhombic crystals diffract to 2.5 A. Both the hexagonal and orthorhombic forms are suitable for crystallographic studies.
INTRODUCTION
Phosphatidylinositol-specific phospholipase C (PI-PLC)
(EC 3.1.4.10) cleaves phosphoinositides into two parts:
the lipid-soluble diacylglycerol, and the phosphorylated
water-soluble inositol headgroup. An increasing number
of PI-PLCs are being found in both eukaryotes and pro-
karyotes. They are secreted by a variety of bacteria, in-
cluding Bacillus cereus ( 1, 2) and the closely related Ba-
cillus thuringiensis (3, 4), the human pathogens Staphy-
lococcus aureus (5) and Listeria monocytogenes (6-8),
and the marine bacterium Cytophaga sp. (NCMB 1314,
9). PI-PLC is one of three classes of enzymes that have
phospholipase C activity. Another type is phosphatidyl-
choline-hydrolyzing phospholipase C (PC-PLC, some-
times called lecithinase). PC-PLC is less specific, hydro-
lyzing phosphatidylcholine, phosphatidylethanolamine,
and phosphatidylserine. The crystal structure of a phos-
phatidylcholine-hydrolyzing phospholipase from B. cer-
eus has been reported ( 10). A third enzyme with a phos-
pholipase C-like activity is sphingomyelinase. These lat-
ter two enzymes do not hydrolyze PI. There appears to
be little or no sequence homology between these three
types of phospholipases C.
The bacterial PI-PLCs also cleave glycosylphosphati-
dylinositol (GPI), a derivative of PI, and thus release
GPI-anchored proteins from membrane surfaces ( 11).
The parasitic protozoan Trypanosoma brucei has a GPI-
PLC thought to play a role in the ability oftrypanosomes
to shed the variable surface glycoprotein (12-15). The
malaria-causing Plasmodiumfalciparum evidently has a
PI-PLC activity ( 16, 17), as has the cellular slime mould
Dictyostelium discoideum ( 18).
In higher eukaryotes, PI-PLCs are involved in signal
transduction. Drosophila PI-PLCs have been reported
( 19-21 ), and an avian PI-PLC from turkey erythrocytes
has been sequenced (22, 23). Mammalian PI-PLCs have
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been found in nearly all tissues examined (for reviews
see 24-26). In some mammalian cells in culture, PT-
PLC activity is also present on the exterior surface (27,
28). In addition, PI-PLCs are being reported in higher
plants (29, 30).
The purpose of this paper is to report the successful
crystallization of a member of the PI-PLC family of en-
zymes. We selected the B. cereus PI-PLC because it is a
relatively small enzyme (35 kD) compared to the PI-
PLCs of higher eukaryotes (85-155 kD). Also, the B.
cereus PI-PLC has been overexpressed in E. coli so that
sufficient quantities are available for x-ray crystallogra-
phy studies (31 ).
MATERIALS AND METHODS
Chemicals and biochemicals
Polyethylene glycol ofaverage molecular weight 600 (PEG 600; Sigma
Chemical Co., St. Louis, MO), sodium citrate dihydrate ("Baker Ana-
lyzed" grade; J. T. Baker Inc., Phillipsburg, NJ), HEPES (free acid;
Calbiochem, La Jolla, CA) and myo-inositol (Aldrich Chemical Co.,
Milwaukee, WI; and Sigma Chemical Co., St. Louis, MO) were used
without further purification. Precipitant solutions for growing ortho-
rhombic crystals, as well as total systems used to determine the phase
diagram and PI-PLC partitioning, were prepared from the following
stock solutions: 1 M and 1.6 M sodium citrate dihydrate, pH to 7.3
with HCI; I M HEPES, pH to 7.9 with NaOH; 0.5 M myo-inositol.
These solutions were sterilized using cellulose acetate membrane filters
(0.2 ,m pore size; Nalgene; Nalge Company, Rochester, NY; or Uni-
flow-25; Schleicher & Schuell, Inc., Keene, NH) and stored in sterile
polypropylene tubes (50 ml capacity) at room temperature. Recombi-
nant B. cereus PI-PLC was isolated from E. coli strain MM294 harbor-
ing the overexpressing plasmid pIC (31 ). The protein was stored in 20
mM Tris-HCI, pH 8.5, at -20°C. All aqueous solutions were prepared
using sterile filtered deionized water. All our preparations contain no
stabilizing or antimicrobial agents.
Crystallization
The B. cereus PI-PLC used for crystallization was transferred from 20
mM Tris-HCI, pH 8.5, to water by repeated ultrafiltration (Centricon-
10; Amicon, Inc., Beverly, MA). The PI-PLC concentration in water
was usually 6-8 mg/ml. All crystallization experiments were carried
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out by vapor diffusion in hanging drops (32). Hanging drops were
prepared by mixing 2-10 Al ofprotein with an equal volume ofprecipi-
tant solution on glass cover slips (No. 2, round, 22 mm; VWR Scien-
tific, Inc., Media, PA) which had been treated with siliconizing solution
(AquaSil; Pierce, Rockford, IL/or Prosil-28; PCR Inc., Gainesville,
FL). These cover slips were inverted and sealed over 1 ml ofhypertonic
reservoir solution (either precipitant or sodium chloride solution) in
24-well Linbro plates (Cat. No. 76-033-05; Flow Laboratories,
McLean, VA).
Hexagonal crystals. Initially, in a screen of conditions using PEG as
precipitating agent, hexagonal microcrystals formed in the presence of
5% (wt/vol) PEG 8000,50mM Tris-HCl, pH 7. Further crystallization
trials were conducted using the sparse matrix sampling approach of
Jancarik and Kim (33). Forty six of the fifty trial conditions of these
authors were carried out, with one modification: the respective solu-
tions were diluted 1:1 with water. Four sets of conditions yielded hexag-
onal crystals: (a) 0.1 M magnesium chloride, 50mM Tris-HCl, pH 8.5,
and 15% PEG 8000; (b) 0.1 M ammonium sulfate, 50mM cacodylate,
pH 6.5, and 15% PEG 8000; (c) 0.1 M sodium acetate, 50 mM Tris-
HCI, pH 8.5, and 15% PEG 4000; and (d) 0.1 M ammonium sulfate,
and 15% PEG 8000, pH 6.3 (unadjusted). These trials yielded no addi-
tional crystal morphologies. We experienced some difficulty in repro-
ducing these crystals. However, by varying the growing conditions,
crystals were almost always obtainable. The largest crystals grew in the
presence of 15% PEG 4000, 0.15 M sodium acetate, and 0.1 M Tris-
HCI, pH 8.5.
Orthorhombic crystals. The first orthorhombic crystals of B. cereus
PI-PLC were grown at 4°C in the presence of 0.2 M sodium citrate, pH
5.6 and 45% PEG 600. This set of conditions gave small twinned crys-
tals overnight. By changing the precipitant solution to 0.3 M sodium
citrate, 28% PEG 600, 50mM myo-inositol and 10 to 100mM HEPES,
pH 7.9, we have produced the larger single rods with a rectangular
cross-section discussed below. Crystallization drops typically consisted
of 10 ,ul protein solution mixed with 10 ,ul precipitant solution sus-
pended over a reservoir of precipitant solution. Most drops gave
hundreds of small crystals or no crystals at all. In order to find the
optimal hypertonicity of the reservoir solution, drops were placed over
a series of increasing sodium chloride concentrations (2.0-3.0 M so-
dium chloride in 50mM increments). Single crystals suitable for X-ray
diffraction data collection grew over 2.55 M sodium chloride at 4°C.
Phase diagram for the PEG-citrate
system
The phase diagram was determined by the general approach described
by Albertsson for aqueous two phase systems (34). In 15 ml conical
centrifuge tubes (graduated at 0.1 ml increments), total systems con-
taining PEG 600, sodium citrate, myo-inositol and HEPES at concen-
trations given in Table 1 were prepared by dilution of the appropriate
stock solutions. To accelerate the separation ofthe two aqueous phases,
the preparations were centrifuged at 1,500 g for 5 min. The total vol-
ume (V0), as well as the volumes of upper (Vu) and lower phases (VL)
were read directly from the graduated centrifuge tubes (see Table 1).
All procedures were performed at room temperature. The concentra-
tions of PEG 600, sodium citrate and myo-inositol were determined by
NMR on a Nicolet QE-300. Samples consisted of an aliquot of the
phase to be analyzed plus 1/7 the volume of 40% sodium benzoate (to
give a final concentration of 5% sodium benzoate in each sample, pro-
viding an internal standard for concentration). NMR measurements
were on 20yd of sample combined with 0.4 ml of D20. The concentra-
tions of PEG 600, sodium citrate and myo-inositol in each phase were
calculated from the peak area relative to the sodium benzoate standard,
the concentration of the component in the total system, and the mea-
sured volumes ofthe phases. For example, the concentration of a com-
ponent in the lower phase is given by:
CL = ALVOCO
AuVu + ALVL
(1)
where CL and C0 are concentrations of PEG 600, sodium citrate or
inositol in the lower phase and the total system, respectively; VL, VU,
and V0 refer to the respective volumes of lower and upper phase and of
the total system. The relative NMR peak areas of the component for
which the concentration is to be calculated are given by AL (lower
phase) and AU (upper phase).
Protein distribution between the PEG-
rich and sodium citrate-rich phases
In a typical experiment, the buffer of the purified protein at 20.6 mg/
ml was exchanged for 93 mM HEPES, pH 7.9 by repeated ultrafiltra-
tion (Centricon- 10) and the protein concentration was adjusted to 16.3
mg/ml. The concentration of PI-PLC was determined spectrophoto-
metrically as follows. The amino acid sequence of the mature PI-PLC
protein from B. cereus, deduced from the nucleotide sequence of its
coding region (35), was used to calculate the molar extinction coeffi-
cient by the method of Gill and von Hippel (36). The calculated value
is E2-n = 1.83. To provide a linear relation of PI-PLC concentration
and absorbance at 280 nm, protein dilutions giving an A280 < 0.6 were
used. Small volumes ( 160 ,ul) of total systems containing /4 or l/8 vol-
ume of 16.3 mg/ml PI-PLC were prepared in 0.65 ml microcentrifuge
tubes. After brief vortexing to mix the components, complete phase
separation was obtained after centrifugation at 12,000 g for 5 min.
Volumes were determined by comparison to standard volumes in iden-
tical tubes. All procedures were performed at room temperature. The
phases were removed and diluted 1:40 (upper phase) or 1:20 (lower
phase) in water for measuring absorbance at 280 nm. The blanks for
the spectrophotometer measurements were 1:40 or 1:20 dilutions of
upper and lower phase from total systems without PI-PLC but other-
wise identical.
X-ray diffraction
X-rays were generated from a Rigaku RU200 rotating copper anode
source and CuKa ( 1.54 A) radiation selected with a graphite mono-
chromator. We examined diffraction and obtained screened precession
photographs on Kodak direct exposure x-ray film DEF-5. Three-di-
mensional data were collected on a Xuong-Hamlin area detector (37).
RESULTS AND DISCUSSION
Hexagonal crystals of B. cereus PI-PLC
Small hexagonal crystals were obtained using PEG 8000
as the precipitant (Fig. 1). The largest crystals we ob-
served were on the order of0.12mm x 0.12mmx 0.35
mm. The crystals were mounted with their long axes
perpendicular to the x-ray beam. A series of still photo-
graphs at various rotations about this axis show equiva-
lent zones at 600 intervals. These zones are interspersed
with another set of zones, 300 away. Both zones display
mm symmetry, as seen on screened precession photo-
graphs. Only hexagonal space groups have such equiva-
lent zones, axially spaced at 600, with mm symmetry.
The major zone (hOl) was identified based on its more
closely spaced layer lines, relative to the diagonal zone.
The two zones have a common row ofreflections, related
to the axis of rotation between them, which only shows
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TABLE 1 Phase compositions for the aqueous two-phase systems containing PEG 600 and sodium citrate
Total system*$ Upper phase§ Lower phase§
CO VO CU VU CL VL
PEG Na PEG Na PEG Na
600 citrate 600 citrate 600 citrate
% (vol/vol) [Ml [ml] % (vol/vol) [Ml [ml] % (vol/vol) [M] [ml]
a 40.00 0.43 10.2 51.58 0.05 7.9 0.22 1.72 2.3
b 37.30 0.40 10.9 48.15 0.08 8.8 0.74 1.49 2.5
c 35.00 0.38 11.8 44.15 0.11 9.3 0.95 1.36 2.5
d 31.10 0.33 13.3 36.18 0.19 11.3 2.40 1.12 2.0
* The composition of a total system states the concentration of all components in this preparation regardless of their distribution between the
phases. All systems were prepared and analyzed at room temperature (23°C).
* The total systems also contained HEPES (50 mM) and myo-inositol (71 mM in a, 67 mM in b, 63 mM in c, and 56 mM in d). Additional data were
recorded at constant myo-inositol (50 mM) concentration. The phase diagram was the same within experimental error.
§ The concentrations ofPEG 600 and Na citrate in upper and lower phases were determined usingNMR as described under Materials and Methods.
every sixth reflection, compared to neighboring rows.
This row suggests a 6,-screw operator along the c axis.
In the hkO photograph of the diffraction pattern,
twelve symmetry mates are present for each reflection.
This can only occur in our hexagonal space group if
there are 2-fold axes of symmetry perpendicular to the
6-fold screw axis. We therefore assign the space group to
be P6,22 (or the enantiomorphic space group, P6522).
This space group has twelve asymmetric units per unit
cell.
We determined cell constants from an hOl precession
photograph. The distance between reflections on the hOO
layer line indicates the cell parameters a = b = 133 A.
From the distance between = 6n reflections on the 001
layer, c is calculated to be 231 A. The unit cell volume
(V) is V = a2c sin 600 = 3.54 x 106 A3 or 295 x 103 A3
per asymmetric unit. To determine the most likely num-
FIGURE Light microscope photograph of hexagonal crystals of B.
cereus PI-PLC. The hanging drop was prepared from 2 ,l to 3 ,u of
about 8 mg/ml PI-PLC in distilled water, added to an equal amount of
a precipitant solution containing 0.1 M ammonium sulfate and 15%
(wt/vol) PEG 8000, pH 6.3. The drop was suspended over a 1 ml
reservoir of the precipitant solution at room temperature. The largest
crystal is approximately 0.05 x 0.1 mm.
ber of PI-PLC monomers in each asymmetric unit we
assumed a crystal packing parameter of2.15 A3/Dalton.
This is the most commonly observed value in a survey of
solved protein structures reported by Matthews (38).
The resulting number of 35 kD proteins that can be ac-
commodated in the asymmetric unit is 3.9. Thus, there
are probably 4 PI-PLC monomers in each asymmetric
unit of the hexagonal unit cell (2-5 are possibilities).
Phase diagram for the PEG 600-
sodium citrate system and partitioning
of PI-PLC in the two phases
In our experience, orthorhombic PI-PLC crystals can be
grown in PEG 600 and sodium citrate containing preci-
pitant solution after phase separation occurs in the hang-
ing drop, following partial dehydration of the hanging
drop (usually >50%). Polyethylene glycols with other
polymers, or certain combinations ofwater-soluble poly-
mers and salt, cause separation into two aqueous phases,
depending on the concentration of solutes. Although
polyethylene glycols are frequently employed as precipi-
tating reagents in protein crystallization studies (32, 39),
these phase separations are rarely explored in detail.
However, in the field of industrial-scale bioseparations,
there is an extensive literature on aqueous two-phase sys-
tems based on two water soluble polymers, for example
PEG and dextran (34, 40). These polymers, or certain
combinations of water soluble polymers and salts, cause
a separation into two aqueous phases. Proteins and other
biological macromolecules added to these systems parti-
tion unequally between the two phases, and this parti-
tion provides the basis for protein isolation. In one study
particularly relevant to the present work, Vernau and
Kula (41 ) examined a series of aqueous two-phase sys-
tems resulting from mixtures ofPEG 400 to 20,000 and
sodium citrate. Their goal was to develop a system for
extracting enzymes from cell homogenates based on bio-
degradable citrates. During the course of their work,
Vernau and Kula established that PEG and sodium ci-
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FIGURE 2 Phase diagram for the PEG 600-sodium citrate system at
room temperature (23°C). The concentrations of the system compo-
nents were selected to match those of the actual orthorhombic crystal
growing solutions. (A) Total PEG 600 and sodium citrate concentra-
tions for the four systems (a-d) ofTable 1. (B, C) Nodes ofthe tie lines
corresponding to compositions of the upper and lower phases, respec-
tively. Also plotted on this phase diagram are the total compositions of
four other systems ( 1-4, open squares) that additionally contained PI-
PLC and were used to measure the partitioning of the protein (see
Table 2). (P) is an estimate of the critical point.
trate will form a two-phase system in the absence ofany
added protein, and that a range of proteins (e.g., leucine
dehydrogenase, alanine dehydrogenase, R-oxynitrilase,
alcohol dehydrogenase, and glucose-6-phosphate reduc-
tase) are concentrated in the upper PEG-rich phase.
Since our conditions are different from those examined
by Vernau and Kula, we have determined the appro-
priate phase diagram for the PEG 600-sodium citrate
system. The aim is to provide a better understanding of
the PI-PLC crystal growth conditions, and to provide a
basis for minimizing complications (e.g., crystal imper-
fections and perforations arising from contact with multi-
ple droplets of the second phase during crystal growth).
The phase diagram for the PEG 600-sodium citrate
system is shown in Fig. 2. PEG 600 and sodium citrate
are both quite soluble in water, yet the two compounds
together are incompatible and cause a separation into
two phases when present in sufficiently high concentra-
tions. By convention, the component enriched in the top
phase is plotted on the ordinate and the component con-
centrated in the bottom phase on the abscissa. Mixtures
with compositions below the curved line (binodial) pro-
duce a single homogeneous phase, whereas above this
line, phase separation occurs. In Fig. 2, the points a-d
are the total compositions selected to generate the bino-
dial. The straight lines are tie lines. The line passing
through a, for example, connects the points on the bino-
dial representing the compositions of the two phases in
equilibrium with the system of total composition repre-
sented by a. Volumes and densities of the phases, con-
centration of their components and distances on the tie
lines AC and AB are related by:
(2)
where volumes and concentrations are defined as in the
Materials and Methods (we neglect the small differences
in densities of the two phases, and take du dL). Myo-
inositol, detected in lower phase only, and HEPES,
which was found evenly distributed between the phases,
were omitted from Fig. 2, for clarity.
The phase diagram explains several observations re-
garding the growth conditions ofthe orthorhombic crys-
tals. Initially, the hanging drop consists of one homoge-
neous phase, corresponding to points well below the bi-
nodial of Fig. 2 (e.g., 14% PEG 600 and 0.15 M sodium
citrate). As vapor diffusion progresses, the concentra-
tions of PEG 600 and sodium citrate increase, until a
phase separation occurs. PI-PLC crystal growth appears
to be supported only in the upper but not in the lower
phase. The phase separation is a property of the PEG
600-sodium citrate system, and is not caused by the
PI-PLC.
To examine the partitioning of B. cereus PI-PLC be-
tween the two aqueous phases, total systems were pre-
pared analogous to those in the phase diagram (Fig. 2)
except that PI-PLC was added. The results are tabulated
in Table 2. We found a distinct preference ofPI-PLC for
the PEG-rich phase, with partition coefficients (K = Cu
C0) that correlate with the concentration ofPEG 600 in
the upper phase (K values for systems 1-4 are K1 = 2.4,
K2 = 5.9, K3 = 16.5, K3b = 17.5, K4 = 35.0, respectively).
Thus, one effect ofthe phase separation is to concentrate
the protein in the upper phase.
These results are in agreement with the protein separa-
tion studies of Vernau and Kula (41 ). At first glance,
they might appear to be at variance with a report by
Alber et al., (42) that yeast triose phosphate isomerase is
concentrated in the bottom phase ofa PEG4000-ammo-
nium sulfate system. However, it is well known that
changes in the ions present can cause shifts in equilib-
rium concentrations of protein and other components
between the upper and lower phases (34). In fact, Ver-
nau and Kula (41 ) make use of this fact in a second step
of their protein purification protocol. They were able to
shift the protein concentration from the top PEG-rich
phase to the bottom phase by replacing sodium citrate
with sodium chloride. Thus, our results are consistent
with the available literature.
By preparing systems 1-4 (Table 2), but omitting PI-
PLC or adding myo-inositol or both (i.e., adding protein
and myo-inositol), and comparing the volumes ofupper
and lower phases to those of systems 1-4, we detected
volume differences only for variations of system 1, and
these were small. Considering that modifications of sys-
tem 1 occur nearest to the critical point P (see Fig. 2),
the point where the property of a two phase system is
most sensitive to variation in its composition (34), these
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TABLE 2 Distribution of B. cereus PI-PLC between the PEG-rich (upper) phase and the sodium citrate-rich (lower) phase
Total system**
coVO Upper phase Lower phase
CU VU CL VL
PEG Na citrate
600 pH 7.3 PI-PLC PI-PLC PI-PLC
% (vol/vol) [M] [mg/ml]O [A1" [mg/ml]' [p1]1l [mg/ml], [/41]1
1 19.3 0.55 4.1 160 5.1 105 2.1 55
2 20.2 0.57 4.1 160 5.9 100 1.0 60
3 21.0 0.60 4.1 160 6.6 90 0.4 70
3b** 21.0 0.60 2.0 160 3.5 90 0.2 70
4 22.7 0.64 2.0 160 3.5 90 0.1 70
* see annotation Table 1.
The total systems further contained 23.2 mM HEPES.
§ 16.3 mg/ml ofPI-PLC in 93 mM HEPES, pH 7.9, was added to the systems (I1-4) to give the indicated PI-PLC concentrations. In (3b) and (4), the
buffer concentration was adjusted by adding the appropriate volume of93 mM HEPES. At higher concentrations ofPEG 600 and Na citrate protein
precipitation was observed at 4.1 mg/ml, therefore, 2.0 mg/ml PI-PLC were used.
Volume of total system (1-4) prepared (V0), and volumes of upper (Vu) and lower (VL) phases measured after phase-separation.
'The concentration of PI-PLC in the upper and lower phases was determined spectrophotometrically (see Materials and Methods section).
** System (3b) also contained 54.5 mM myo-inositol.
small differences are not surprising. We conclude that
additives (PI-PLC and or myo-inositol) at concentra-
tions used here cause only minor changes in the phase
diagram. Therefore, tie lines of systems 2-4 can be pro-
jected into the phase diagram and the PEG 600 and so-
dium citrate concentrations of upper and lower phases
deduced. Furthermore, we find addition of myo-inositol
to be without influence on the partitioning of PI-PLC
between upper and lower phases (Table 2, 3b) . The pres-
ence of myo-inositol is not required for crystallization of
PI-PLC as shown from our initial precipitant solution
without myo-inositol. However, we find PI-PLC crystals
formed in the presence of myo-inositol to be somewhat
larger in size. The influence of myo-inositol on crystal
growth might be via association with PI-PLC, for which
we have indirect evidence from studies showing a weak
inhibitory effect of myo-inositol on PI-PLC activity
(43). However, any influence of myo-inositol is puz-
zling, since it partitions primarily to the lower phase.
Applying this analysis of the PEG 600-sodium citrate
two phase system and partitioning of PI-PLC between
the phases to crystal growth, we then asked if it is possible
to grow crystals using precipitant solution composed of
upper phase only. A single phase system from which pro-
tein can crystallize would be useful when defined
changes to the precipitant are to be made (e.g., addition
of cofactors or inhibitors) to avoid problems arising
from unequal partitioning of additives between the
phases. In preliminary experiments, we prepared several
total systems consisting of PEG 600, sodium citrate,
myo-inositol and 50 mM HEPES, pH 7.9, and removed
the upper phase. Adding these solutions to an equal vol-
ume of protein solutions, we were able to grow ortho-
rhombic crystals ofPI-PLC at 4°C by the vapor diffusion
technique. The crystals obtained were comparable to
those of Fig. 3. From the phase diagram, and assuming
vapor diffusion equilibrium with the well solution, we
estimate the hanging drop contained between 36% PEG
600 and 0. 19 M sodium citrate to 42% PEG 600 and 0. 13
M sodium citrate. These results indicate that factors in-
herent in the process of phase separation per se, such as
the presence of an interface or the gradual removal of
citrate, are not essential for crystal growth.
Orthorhombic crystals of B. cereus
PI-PLC
Representative crystals of the orthorhombic form of B.
cereus PI-PLC are shown in Fig. 3. These crystals are
somewhat larger and more easily obtained than the hex-
FIGURE 3 Light microscope photograph of orthorhombic crystals of
B. cereus PI-PLC. In the background can be seen the droplets of a
second phase. From the phase diagram and from PI-PLC partitioning
between phases, this is identified as the sodium citrate-rich phase. The
hanging drop was prepared from 7.5 ul of 9 mg/ml PI-PLC in 20 mM
HEPES, pH 7.9, and 7.5 ,l of 28% (vol/vol) PEG 600, 0.3 M sodium
citrate, 50 mM myo-inositol. The drop was suspended over a 1 ml
reservoir of 2.6 M NaCl at 4°C. The length of the bar is 0.2 mm.
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A, b = 46 A, c = 160 A. These unequal perpendicular cell
axes are consistent with an orthorhombic unit cell. The
systematic absences and mm symmetry seen on all three
principal axes are consistent with space group P212,2,.
This space group has four asymmetric units per unit cell.
The volume (V) of the orthorhombic unit cell is V =
abc = 3.31 x I0 A3, and thus the volume ofeach ofthe
four asymmetric units is 82.8 X 103 A3. Assuming one
monomer of PI-PLC (35 kD) per asymmetric unit, the
molecular volume (Vm) is 2.38 A3!/Dalton. This value is
near the most common observed value of the packing
parameter for known protein structures (38). Two
monomers per unit cell would be highly unlikely because
the corresponding Vm ( 1. 19 A 3/D) is well below the low-
est observed value of this distribution.
X-ray diffraction from orthorhombic PI-PLC crystals
extends to 2.5 A resolution on our multi-wire area detec-
tor. In 48 hours, we collected the 20 A-2.8 A data sum-
marized in Table 3. The statistics show a high complete-
ness and redundancy. Between 20 A and 3 A, 9 1% ofthe
independent reflections were measured, with each being
measured an average of 3.5 times. The final R-factor of
0.046 indicates that data can be collected reliably to at
least 2.8 A. We intend to pursue the three-dimensional
structure determination of B. cereus PI-PLC using the
standard technique of multiple isomorphous replace-
ment, and the search for suitable heavy atom derivatives
is under way.
FIGURE 4 X-ray diffraction pattern of an orthorhombic crystal of B.
cereus PI-PLC. 120 precession photograph of the hOl zone (h vertical, /
horizontal).
agonal crystals ofPI-PLC, typically reaching dimensions
ofabout 0.05 mm x 0.1 mm x 1.0 mm. The orthorhom-
bic crystals diffract surprisingly well for their relatively
small size. We routinely obtain 12° screened precession
photos in 24 hours.
By aligning the long axis of the brick-shaped crystals
perpendicular to the beam and taking still x-ray photo-
graphs, we found two principal zones. These are related
to each other by a 900 rotation about the crystal's long
axis. A third principal zone is obvious when the crystal is
oriented with its long axis parallel to the beam. We deter-
mined the cell constants and space group of these crys-
tals from screened precession photographs of the three
major zones. All three zones (hkO, hOl, and Okl) have
mm symmetry and a common set of missing reflections.
In the central horizontal and vertical rows, only alternate
reflections are present. In the case of the hOl picture (see
Fig. 4), these reflections are h = 2n on the hOO axis and
1= 2n on the 001 axis. Only k = 2n reflections are present
on the OkO axis as judged from the Okl and hkO photo-
graphs.
The spacings between layer lines on these pictures
were measured by hand and indicate constants ofa = 45
CONCLUSIONS
Two crystal forms ofB. cereus PI-PLC are reported. This
is evidently the first member of the large class of PI-spe-
cific phospholipase C enzymes to be crystallized. Small
hexagonal crystals were grown from a single phase solu-
tion with PEG 8000 as the precipitating agent. Ortho-
rhombic crystals were obtained from a more complex
two phase system utilizing low molecular weight PEG
(600 D) and sodium citrate. In order to provide a ratio-
nal basis for understanding the crystallization process,
the phase diagram was determined for the PEG 600 so-
TABLE 3 Data collection for the orthorhombic form
of B. cereus PI-PLC
Number of
Resolution unique Percentage of Average
range (A) reflections data redundancy R-factor*
oo-4.72 1864 94.4% 4.72 0.031
4.72-3.75 1718 94.3% 3.76 0.039
3.75-3.27 1656 92.2% 3.09 0.063
3.27-2.97 1646 91.0% 2.67 0.101
2.97-2.76 1057 59.5% 1.68 0.123
oo-2.76 7941 86.5% 3.34 0.046
* The R-factor (R-merge) was calculated as: sum (abs (ave - obs))/sum
(ave), where ave is the average intensity of all the observed intensities
(obs) for each reflection.
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dium citrate system under the crystal growth conditions.
Phase separation occurs spontaneously when PEG 600
and sodium citrate solutions are combined in the appro-
priate amounts, and it is not due to the PI-PLC. One
effect ofthe phase separation, which occurs slowly in the
hanging drop, is to concentrate PI-PLC in the upper
PEG-rich phase, thus promoting crystallization. The
phase diagram can be used to control the amount of the
two phases present, and thus to minimize crystal imper-
fections caused by interference ofdroplets ofthe sodium
citrate phase in the vicinity of crystals growing in the
PEG-rich phase. Both crystal forms are suitable for crys-
tallographic studies of B. cereus PI-PLC.
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